Stem Cells therapy

Issues of congenital heart disease

  Issues of congenital heart disease Location: Kiev,Ukraine Start Date: 2012-09-23 End Date: 2012-09-24 Conditions of participation for participants: Registration Package   includes transportation ( from\to airport, from\to conference venue), simultaneous translation from Ukrainian or Russian to English language , certificate of Read more…

By NBScience, ago
Stem Cells therapy

Надлежащая производственная практика (cGMP)

Надлежащая производственная практика (cGMP)   Целевая аудитория Курс предназначен для всех ученых (управленческий и лаборатории) и профессионалов в области биотехнологий, биофармацевтической, устройство, косметической, фармацевтической промышленности и агрохимикатов, чья работа функции, связанные с наркотиками / биологических Read more…

By NBScience, ago
Auditor GCP

Auditor, GCP

Auditor, GCP Responsibilities The GCP Auditor is responsible for quality assurance auditing of all activities subject to the, “ICH Good Clinical Practice: Consolidated Guideline,” (GCPs), supporting a program of quality assurance (QA) to ensure that Read more…

By NBScience, ago
anesthesia conferences

Medical meetings in Ukraine

Today we have analyzed the popularity of medical conferences in Ukraine. Yes, may be it’s not such  popular conferences, but  level of training of lecturers and   level of knowledge gained at conferences in Kiev is very high. Also interested in the existence of various social programs organized by the company NBScience (interview with Read more…

By NBScience, ago
clinical research

Good Clinical Practice

Good Clinical Practice

The tripartite harmonised ICH Guideline was finalised under Step 4 in May 1996. This Good Clinical Practices document describes the responsibilities and expectations of all participants in the conduct of clinical trials, including investigators, monitors, sponsors and IRBs. GCPs cover aspects of monitoring, reporting and archiving of clinical trials and incorporating addenda on the Essential Documents and on the Investigator's Brochure which had been agreed earlier through the ICH process.
Step 5
Adopted by CPMP, July 1996, issued as CPMP/ICH/135/95/Step5, Explanatory Note and Comments to the above, issued as CPMP/768/97
Adopted March 1997, PAB Notification No. 430, MHLW Ordinance No. 28
Published in the Federal Register, 9 May 1997, Vol. 62, No. 90, p. 25691-25709

By NBScience, ago
stem cell therapy